These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15525559)

  • 1. Statistical limitations to the Cornell model of latent tuberculosis infection for the study of relapse rates.
    Lenaerts AJ; Chapman PL; Orme IM
    Tuberculosis (Edinb); 2004; 84(6):361-4. PubMed ID: 15525559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct comparison of low-dose and Cornell-like models of chronic and reactivation tuberculosis in genetically susceptible I/St and resistant B6 mice.
    Radaeva TV; Nikonenko BV; Mischenko VV; Averbakh MM; Apt AS
    Tuberculosis (Edinb); 2005; 85(1-2):65-72. PubMed ID: 15687029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A refined symptom-based approach to diagnose pulmonary tuberculosis in children.
    Marais BJ; Gie RP; Hesseling AC; Schaaf HS; Lombard C; Enarson DA; Beyers N
    Pediatrics; 2006 Nov; 118(5):e1350-9. PubMed ID: 17079536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human-like TB in genetically susceptible mice followed by the true dormancy in a Cornell-like model.
    Radaeva TV; Kondratieva EV; Sosunov VV; Majorov KB; Apt A
    Tuberculosis (Edinb); 2008 Nov; 88(6):576-85. PubMed ID: 18667358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine models of susceptibility to tuberculosis.
    Beamer GL; Turner J
    Arch Immunol Ther Exp (Warsz); 2005; 53(6):469-83. PubMed ID: 16407780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PGRS domain of Mycobacterium tuberculosis PE_PGRS Rv1759c antigen is an efficient subunit vaccine to prevent reactivation in a murine model of chronic tuberculosis.
    Campuzano J; Aguilar D; Arriaga K; León JC; Salas-Rangel LP; González-y-Merchand J; Hernández-Pando R; Espitia C
    Vaccine; 2007 May; 25(18):3722-9. PubMed ID: 17399860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficiency of anti-inflammatory therapy for experimental tuberculosis in genetically tuberculosis-sensitive mice].
    Kondrat'eva TK; Rubakova EI; Evstifeev VV; Sosunov VV; Petrovskaia SN; Kondrat'eva AV; Apt AS
    Probl Tuberk Bolezn Legk; 2006; (10):63-5. PubMed ID: 17139836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic architecture of tuberculosis resistance in a mouse model of infection.
    Yan BS; Kirby A; Shebzukhov YV; Daly MJ; Kramnik I
    Genes Immun; 2006 Apr; 7(3):201-10. PubMed ID: 16452998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis.
    Derrick SC; Perera LP; Dheenadhayalan V; Yang A; Kolibab K; Morris SL
    Vaccine; 2008 Nov; 26(48):6092-8. PubMed ID: 18809446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models of M. tuberculosis Infection.
    Orme I; Gonzalez-Juarrero M
    Curr Protoc Microbiol; 2007 Nov; Chapter 10():Unit 10A.5. PubMed ID: 18770606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Exogenous re-infection in tuberculosis].
    Tsuchiya T
    Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis.
    Castañon-Arreola M; López-Vidal Y; Espitia-Pinzón C; Hernández-Pando R
    Tuberculosis (Edinb); 2005; 85(1-2):115-26. PubMed ID: 15687035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mouse model of the recrudescence of latent tuberculosis in the elderly.
    Orme IM
    Am Rev Respir Dis; 1988 Mar; 137(3):716-8. PubMed ID: 3345049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental approaches to designing vaccines against tuberculous infection reactivation].
    Radaeva TV; Nikonenko BV; Kapina MA; Mishchenko VV; Apt AS
    Probl Tuberk Bolezn Legk; 2006; (5):45-8. PubMed ID: 16850924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication of small effect quantitative trait loci for behavioral traits facilitated by estimation of effect size from independent cohorts.
    Bennett B; Carosone-Link P
    Genes Brain Behav; 2006 Jul; 5(5):404-12. PubMed ID: 16879634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of non-tuberculous pulmonary mycobacteriosis].
    Sakatani M; Nakajima Y
    Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size calculations for a split-cluster, beta-binomial design in the assessment of toxicity.
    Hendriks JC; Teerenstra S; Punt-Van der Zalm JP; Wetzels AM; Westphal JR; Borm GF
    Stat Med; 2005 Dec; 24(24):3757-72. PubMed ID: 16320284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models of tuberculosis.
    Gupta UD; Katoch VM
    Tuberculosis (Edinb); 2005; 85(5-6):277-93. PubMed ID: 16249122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.